In new guidance NICE recommends the use of apremilast (Otezla) for certain patients with chronic plaque psoriasis unresponsive to other systemic therapies.
Treatment with the topical rosacea treatment brimonidine (Mirvaso) should be started at a low dose and increased gradually to reduce the risk of exacerbating the condition, the MHRA has advised.
Register or Subscribe to MIMSGPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.
MIMS bulletinsNews and updates straight to your inbox.
Prescribing Update: Fortnightly news bulletin
Alert: Urgent prescribing updates
Spotlight: Disease-themed monthly round-up
Read the latest issue online exclusively on MIMS Learning.
Especially created for prescribing influencers.